Back to Results
First PageMeta Content
Research exemption / Intellectual property law / Pharmaceutical sciences / Drug Price Competition and Patent Term Restoration Act / Food and Drug Administration / Patent / Waxman / Copyright law of the United States / Roche Products v. Bolar Pharmaceutical / Law / Patent law / Clinical research


PRESENTATION: RESEARCH TOOLS IN THE BIOTECHNOLOGY INDUSTRY AND THE HATCH-WAXMAN ACT Robert Blackburn*
Add to Reading List

Document Date: 2004-10-06 18:13:29

Open Document

File Size: 34,34 KB

Share Result on Facebook

City

Milwaukee / Chicago / /

Company

SIBIA Neurosciences Inc. / Ventritex Inc. / Cadus Pharm / Intermedics Inc. / Chiron Corporation / Hecht Co. / Bolar Pharm / /

Country

Germany / United States / /

Currency

USD / /

Event

Patent Issuance / /

Facility

University of Michigan / /

IndustryTerm

pharmaceutical discovery / final product / pharmaceuticals / biotechnology / throughput assay technologies / research tool technology / biotechnology industry / pharmaceutical field / large pharmaceutical / chemical entity / biotechnology tools / /

MedicalCondition

particular disease / /

Organization

Congress / Supreme Court / US Federal Reserve / U.S. court / University of Michigan / FDA / /

Person

Toshiko Takenaka / Micky Eisenberg / Kraig Hill / Kevin Takeuchi / Rader / /

Position

author / actor / etc / Judge / forward in development / /

ProvinceOrState

Michigan / /

Technology

combinatorial chemistry / research tool technology / high throughput assay technologies / BIOTECHNOLOGY / /

SocialTag